Genetic Testing Services

Selected news for the healthcare topic - Genetic Testing Services, collected since 10/2017. This healthcare topic shares news with COVID-19, NeoGenomics, Reproductive Health, Steve Chapman and dozens of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
10/28/2021 Natera Announces Third Quarter 2021 Earnings Conference Call PR Newswire ... on women's health, oncology, and organ health. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California . It offers proprietary genetic testing services to inform obstetricians, transplant physicians, oncologists, and cancer researchers, including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform. For more information, visit natera.com . Follow Natera on LinkedIn .ContactsInvestor Relations ...
10/24/2021 Australians Using IVF Genetic Testing Can Soon Claim Medicare Rebate - NewsOpener newsopener.com From 1 November, Australians will be able to claim a Medicare rebate for five items covering new pre-implantation genetic testing services provided within the existing IVF process.Types of genetic disorders able to be tested include, but are not limited to, cystic fibrosis, muscular dystrophy, spinal muscular atrophy, fragile X, neurofibromatosis and Huntington’s disease.The government is providing $95.9 million so these services can be reimbursed through Medicare ...
10/23/2021 Genetic Testing Services in healthcare Market is projected to reach US$ 22,701.8 million by 2027; At a CAGR of 11.7% from 2020 to 2027 tradingforkeeps.com ... Genetic testing may be beneficial whether the test identifies a mutation or not. For some people, test results serve as a relief, eliminating some of the uncertainty surrounding their health.The growth of the Genetic Testing Services in healthcare market is attributed to the rising prevalence of the genetic diseases, rise in awareness & acceptance of personalized medicines are expected to boost the market growth over the years. However, cost effectiveness ...
10/21/2021 Sales of Genetic Testing Services Market to Surpass US$ 64.1 Bn by 2025 express-press-release.net Sales of Genetic Testing Services Market to Surpass US$ 64.1 Bn by 2025 Genetic testing services have found widespread applications in several healthcare fields. These include oncology, obstetrics and ancestry. Genetic testing is predominantly used in determining the prevalence of various autoimmune diseases like rheumatoid arthritis, Type-1 diabetes mellitus, multiple sclerosis, cancers and Guillain-Barre syndrome. On the back of these factors, the global genetic testing services market is ...
10/19/2021 NeoGenomics' Liquid Biopsy Subsidiary Inivata Announces Clinical Collaboration With Princess Margaret Cancer Center for the Use of Its Liquid Biopsy Assays illinoisintelligencer.com Two clinical studies including interventional RaDaR™ studyFT. MYERS, FL / ACCESSWIRE / October 19, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that its liquid biopsy focused subsidiary Inivata Limited ('Inivata') has entered into a clinical collaboration with the Princess Margaret Cancer Center in Toronto, Canada, for the use of Inivata's liquid biopsy assays, InVisionFirst® ...
10/19/2021 Two clinical studies including interventional RaDa wapakdailynews.com Two clinical studies including interventional RaDaR™ studyFT. MYERS, FL / ACCESSWIRE / October 19, 2021 / NeoGenomics, Inc. ( NASDAQ:NEO ), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that its liquid biopsy focused subsidiary Inivata Limited ("Inivata") has entered into a clinical collaboration with the Princess Margaret Cancer Center in Toronto, Canada, for the use of Inivata's liquid biopsy assays, InVisionFirst® ...
10/19/2021 NeoGenomics' Liquid Biopsy Subsidiary Inivata Announces Clinical Collaboration With Princess Margaret Cancer Center for the Use of Its Liquid Biopsy Assays neogenomics.com Two clinical studies including interventional RaDaR™ study FT. MYERS, FL / ACCESSWIRE / October 19, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that its liquid biopsy focused subsidiary Inivata Limited ("Inivata") has entered into a clinical collaboration with the Princess Margaret Cancer Center in Toronto, Canada, for the use of Inivata's liquid biopsy assays, InVisionFirst® ...
10/19/2021 NeoGenomics' Liquid Biopsy Subsidiary Inivata Announces Clinical Collaboration With Princess Margaret Cancer Center for the Use of Its Liquid Biopsy Assays portlandnews.net Two clinical studies including interventional RaDaR™ studyFT. MYERS, FL / ACCESSWIRE / October 19, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that its liquid biopsy focused subsidiary Inivata Limited ('Inivata') has entered into a clinical collaboration with the Princess Margaret Cancer Center in Toronto, Canada, for the use of Inivata's liquid biopsy assays, InVisionFirst® ...
10/14/2021 Genetic Testing Services Market Movement-detailed Research Analysis 2019-2027 instanttechnews.com The “Genetic Testing Services Market” globally is a standout amongst the most emergent and astoundingly approved sectors. This worldwide market has been developing at a higher pace with the development of imaginative frameworks and a developing end-client tendency. Genetic Testing Services market reports deliver insight and expert analysis into key consumer trends and behaviour in marketplace, in addition to an overview of the market data and key brands ...
10/13/2021 NeoGenomics Announces Board of Directors' Transition illinoisintelligencer.com ... as Executive Chairman and will retire from the Board of Directors before the end of the yearFT. MYERS, FL / ACCESSWIRE / October 12, 2021 / NeoGenomics, Inc. (NASDAQ:NEO) , a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced today a transition in the leadership of its Board of Directors. Ms. Lynn A. Tetrault, former Lead Independent Director, has been appointed Non-executive Chair of ...
10/13/2021 NeoGenomics Announces Board of Directors' Transition portlandnews.net ... steps-down as Executive Chairman and will retire from the Board of Directors before the end of the yearFT. MYERS, FL 12, 2021 / NeoGenomics, Inc. (NASDAQ:NEO) , a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced today a transition in the leadership of its Board of Directors. Ms. Lynn A. Tetrault, former Lead Independent Director, has been appointed Non-executive Chair of ...
10/13/2021 The Ridgway Record ridgwayrecord.com ... Douglas VanOort steps-down as Executive Chairman and will retire from the Board of Directors before the end of the yearFT. MYERS, FL NeoGenomics, Inc. ( NASDAQ:NEO ) , a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced today a transition in the leadership of its Board of Directors. Ms. Lynn A. Tetrault, former Lead Independent Director, has been appointed Non-executive Chair of ...
10/13/2021 Fulgent Genetics (NASDAQ:FLGT) Upgraded to “Buy” by Zacks Investment Research - Slater Sentinel slatersentinel.com ... to a buy rating in a report issued on Tuesday, Zacks.com reports. The firm currently has $94.00 price target on the stock.According to Zacks, “Fulgent Genetics, Inc. is a technology company. It provide genetic testing services to physicians with clinically actionable diagnostic information. The Company’s technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to ...
10/12/2021 North America Genetic Testing Services Market Overview, Opportunities, In-Depth Analysis, Regional Outlook, Market Analysis packagingnews24.com North America Genetic Testing Services Market Overview, Opportunities, In-Depth Analysis, Regional Outlook, Market Analysis The growth of the market is driven by factors such as rising prevalence of the genetic diseases and rise in awareness & acceptance of personalized medicines. Also, growing preference towards Direct-To-Consumer (DTC) genetic testing, support of government to adopt genetic testing services is positively impacting the growth of the market in the review period ...
10/12/2021 Europe Genetic Testing Services Market Expected to Reach US$ 5,840.9 Mn in 2027 – Thermo Fischer, Laboratory Corporation of America Holdings, F. Hoffmann-La Roche, Illumina, Quest Diagnostic , Exact Sciences, NeoGenomics, Eurofins Scientific, Ambry Genetics packagingnews24.com Europe Genetic Testing Services Market Expected to Reach US$ 5,840.9 Mn in 2027 – Thermo Fischer, Laboratory Corporation of America Holdings, F. Hoffmann-La Roche, Illumina, Quest Diagnostic , Exact Sciences, NeoGenomics, Eurofins Scientific, Ambry Genetics The Europe genetic testing services market is expected to reach US$ 5,840.9 Mn in 2027 from US$ 2,521.6 Mn in 2019. The genetic testing services market is anticipated to grow at a growth rate of ...
10/12/2021 Crwe World | NeoGenomics Announces Board of Directors' Transition crweworld.com ... as Executive Chairman and will retire from the Board of Directors before the end of the yearFT. MYERS, FL / ACCESSWIRE / October 12, 2021 / NeoGenomics, Inc. (NASDAQ:NEO) , a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced today a transition in the leadership of its Board of Directors. Ms. Lynn A. Tetrault, former Lead Independent Director, has been appointed Non-executive Chair of ...
10/12/2021 Appoints Lead Independent Director Lynn Tetrault a wapakdailynews.com ... Douglas VanOort steps-down as Executive Chairman and will retire from the Board of Directors before the end of the yearFT. MYERS, FL NeoGenomics, Inc. ( NASDAQ:NEO ) , a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced today a transition in the leadership of its Board of Directors. Ms. Lynn A. Tetrault, former Lead Independent Director, has been appointed Non-executive Chair of ...
10/6/2021 Growth Momentum over Valuation? By TipRanks streetregister.com ... Bionano Genomics’ strong revenue growth has been driven by the Saphyr implemented base growth. It was adopted by two large UK laboratories that are part of the NHS. Lineagen, the company that offers genetic testing services to people with neurodevelopmental issues for over nine years has performed more than 65,000 of these tests. Company is on the right track to achieving all its milestones for 2021. Latest Results Bionano ...
9/24/2021 Kathleen Gallagher: We need more bold investments in risky startups jsonline.com ... 8 billion — eight times the valuation needed to join the "unicorn club." And as far as I can tell, it doesn’t have any jaw-dropping products on the market.Tempus provides molecular genetic testing services . It says it has the world’s largest library of clinical and molecular data — 3.8 million patient records, 400,000 of which contain genomic information — and that it’s going to apply ...
9/20/2021 Center for Innovation celebrates first incubator graduates ellsworthamerican.com ELLSWORTH — Todd Dehm and Michael Greene, co-founders of Genotyping Center of America (GTCA), were meeting in Bangor from opposite counties as they developed their fledgling genetic testing services company. Former Jackson Lab scientists, they commuted for 18 months before Micki Sumpter, Ellsworth’s economic development director at the time, reached out to them about becoming an “incubator” business for the new Union River Center for Innovation on ...